(4) We established the UGT2B17 transcriptome in the prostate and tumours to corroborate our observations at the protein level, and (5) identified alternative promoters as a mechanism governing UGT2B17 expression in the prostate, localised PCa and metastatic disease. The gene discussed is UGT2B17; the disease is neoplasm.